v3.26.1
Stockholders’ Equity (Details) - USD ($)
 3 Months Ended
Mar. 09, 2026
Nov. 05, 2025
Apr. 06, 2022
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
May 31, 2021
Dec. 31, 2014
Stockholders’ Equity [Line Items]                
Cashless exercise of warrants       2,082,500        
Warrant to purchase shares of common stock 4,210,527              
Offering price (in Dollars per share)   $ 2.2            
Shares issued 29,474,569              
Common stock, price per share (in Dollars per share) $ 0.001     $ 0.001   $ 0.001    
Private investment description The shares of common stock were sold at an offering price of $4.75 per share, and the pre-funded warrants were sold at an offering price of $4.749 per pre-funded warrant, which represents the per share purchase price for the common stock less the $0.001 per share exercise price for each such pre-funded warrant.              
Term of stock options       5 years 5 months 23 days        
Unrecognized stock-based compensation expense (in Dollars)       $ 6,500,000        
Weighted average remaining service period       5 years        
Option [Member]                
Stockholders’ Equity [Line Items]                
Term of stock options       10 years        
Vested term       4 years        
Aggregate fair value of options (in Dollars)       $ 1.38        
Pre-Funded Warrant [Member]                
Stockholders’ Equity [Line Items]                
Shares of its common stock   40,142,000            
Warrant to purchase shares of common stock   5,315,000            
Offering price (in Dollars per share)   $ 2.199            
Warrant exercise price (in Dollars per share)   $ 0.001            
Issuance of warrant (in Dollars) $ 150,000,000 $ 94,000,000   150,000,000        
Warrant [Member]                
Stockholders’ Equity [Line Items]                
Unrecognized stock-based compensation expense (in Dollars)       0        
Intrinsic value of warrants exercisable (in Dollars)       $ 22,552,693        
Two Thousand Fourteen Stock Option and Equity Incentive Plan [Member]                
Stockholders’ Equity [Line Items]                
Common stock grants       15,052,942     9,900,000  
Two Thousand Fourteen Stock Option and Equity Incentive Plan [Member] | Board of Directors [Member]                
Stockholders’ Equity [Line Items]                
Common stock grants             1,500,000 5,152,942
Common Stock [Member]                
Stockholders’ Equity [Line Items]                
Restricted common stock       2,082,032 3,017,420      
Shares issued       29,474,569        
Restricted Common Stock [Member]                
Stockholders’ Equity [Line Items]                
Research and development compensation expense (in Dollars)         $ 905,226      
License Agreement [Member] | Restricted Common Stock [Member]                
Stockholders’ Equity [Line Items]                
Restricted common stock         3,017,420      
Open Market Sale Agreement [Member] | Common Stock [Member]                
Stockholders’ Equity [Line Items]                
Aggregate offering price (in Dollars)     $ 100          
Shares issued